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Fine Particulate Air Pollution and Mortality:
Response to Enstrom’s Reanalysis of the
American Cancer Society Cancer
Prevention Study II Cohort
C. Arden Pope III1, Daniel Krewski2,3,4, Susan M. Gapstur5,
Michelle C. Turner2,6,7,8, Michael Jerrett9, and Richard T. Burnett10
Background
The first analysis of long-term exposures to air pollution and
risk of mortality using the American Cancer Society Cancer
Prevention Study II (ACS CPS-II) cohort was published in
1995.1 Subsequently, extensive independent reanalysis2 and
multiple extended analyses3-7 were conducted. These studies
have consistently demonstrated that exposure to fine particu-
late matter air pollution (PM2.5) is associated with increased
risk of mortality, especially cardiopulmonary or cardiovascular
disease mortality. A recent analysis by Enstrom, based on early
data from the ACS CPS-II cohort, reports no significant rela-
tionship between PM2.5 and total mortality.
8 The author asserts
that the original analyses, reanalyses, and the extended analy-
ses found positive PM2.5–mortality relationships because of
selective use of CPS-II and PM2.5 data.
Expanded Analyses of the ACS CPS-II Cohort
The assertion regarding selective use of the CPS-II and PM2.5
data is false. The scope of analyses of the ACS CPS-II cohort
conducted over more than 2 decades were explicitly expanded
over time to characterize population health risks of PM2.5 in
more detail and with greater accuracy. Table 1 provides an
outline of key published studies of this expansive body of air
pollution research. The highlights of the obvious progress made
during the course of these studies include the following:
1) increased mortality follow-up from 7 to 22 or 26 years;
2) increased number of participants included in the anal-
yses from approximately 295 000 to 670 000;
3) increased number of deaths (a key determinant of study
power) included in the analyses from approximately
21 000 to 237 000;
4) improved assessment of PM2.5 exposures (and expo-
sures of co-pollutants) from metro-level averages for
cities with air pollution monitoring to modeled PM2.5
exposures at geocoded residential addresses throughout
the United States; and
5) improved statistical models, including improved con-
trol for individual and ecological covariates, and better
representation of spatial patterns in the data.
As shown in Figure 1, estimates of the percentage increase
in mortality risk per 10 mg/m3 increase in PM2.5 for all-cause
and for cardiovascular disease mortality from studies using the
ACS CPS-II cohort have been remarkably consistent across the
expanded analyses over the last 20þ years. The recent analysis
by Enstrom8 shows an estimated PM2.5–mortality association
that is smaller than observed in the original analysis, the
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2
reanalysis, multiple subsequent extended analyses, or meta-
analyses of studies throughout the world.18
Deficiencies in Enstrom’s Reanalysis
Enstrom’s recently published analysis8 is the least advanced
analysis of the ACS CPS-II cohort to date (see Table 1). The
Enstrom’s analysis uses a data set with a shorter follow-up
period, fewer participants, and fewer deaths than any previous
PM2.5–mortality analyses that used the CPS-II cohort, includ-
ing the original 1995 analysis. He controls for a relatively
limited number of individual-level covariates and does not
control for any ecologic covariates. Moreover, the key defi-
ciency in the Enstrom’s reanalysis is the absence of advanced
modeling approaches for exposure assessment that have been
developed over the last 2 decades. Estimates of PM2.5–mortal-
ity associations are affected by the quality of the PM2.5 data and
the accuracy of matching participants and exposures. In a
recent analysis,7 we evaluated PM2.5 exposures using multiple
exposure assessment methods. Figure 1 illustrates that there
were significant PM2.5–mortality risk associations for all
PM2.5 measures, but the associations were lower for the pre-
sumably less accurate measures that used remote sensing with-
out ground-based data. Based on measures of model quality,
the PM2.5 exposure values that best fit (lowest Akaike Infor-
mation Criteria, AIC) the data resulted in relatively larger
PM2.5–mortality associations (see Figure 1). In contrast,
Enstrom8 asserts that he estimates smaller PM2.5–mortality
associations because he uses the “best” PM2.5 data. He provides
neither evidence in support of this assertion nor any measures
of the relative quality of models using alternative PM2.5 data. It
is not clear how or why his “IPN” PM2.5 data differ from the
“Health Effects Institute” PM2.5 data—especially given that
these data come from the same monitoring network.
Furthermore, Enstrom’s PM2.5 exposure assessment is likely
subject to greater exposure misclassification because of inade-
quate assignment of geographic units of exposure. Although
other published ACS CPS-II studies assigned geographic areas
of exposure based on participants’ residence information, the
Enstrom’s analysis used the ACS Division and Unit numbers to
assign PM2.5 exposures (see letter from ACS). The ACS Divi-
sion and Unit numbers, however, were for the ACS volunteers
that recruited the participants. These volunteers did not always
live in the same area or even in the same state as the partici-
pants. Enstrom does not document the extent of this
participant-exposure mismatching, but it has the potential for
substantial exposure misclassification and resultant attenuation
bias. Our published research using the ACS CPS-II data is
based on participant-exposure matching that is accurate,
includes highly spatially resolved exposure models, and uti-
lizes ground-based monitoring and land use data.
An inexplicable deficiency of the Enstrom’s article is its
inadequate documentation of the relevant and extensive peer-
reviewed literature. References provided in the article largely
Figure 1.Nationwide estimates of percentage increase in mortality risk per 10 mg/m3 increase in PM2.5 from various published studies using the
ACS CPS-II cohort (indicated by circles) with comparison estimates from meta-analysis of the literature (indicated by diamonds). The size of the
circles is relative to the length of the follow-up period. Gray and white circles indicate metro-level and county-level geographic units of
exposure, respectively. Black circles indicate that exposures were modeled at geocoded residential addresses. Asterisks indicate that, in
addition to controlling for individual covariate, the models also controlled for ecological covariates. Note. (1) Krewski et al2 report the results
of an independent, confirmatory reanalysis of the ACS cohort organized by the Health Effects Institute. (2) In the investigation of alternative
measures of PM2.5 conducted by Jerrett et al,
7 the highest quality models (those with the lowest AIC) produced the highest risk estimates;
remote sensing models with no ground-based data produced the lowest risk estimates, likely because of greater exposure misclassification. (3)
The lowest risk estimate reported by Enstrom8 is based on a dated and short follow-up of the ACS cohort and is likely subject to exposure
mismatching. ACS CPS II indicates American Cancer Society Cancer Prevention Study II; PM2.5, particulate matter air pollution.
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include an unconventional mix of unpublished and non-peer-
reviewed correspondence (including letters, e-mails, and tran-
script of a teleconference call), presentation slides, press
releases, and a compilation of manuscript rejections. Key pub-
lished extended analyses of the ACS CPS-II cohort,3,5,6,7,9-17
studies of other cohorts,18-31 or even major reviews and evalua-
tions of the literature32,33 are not cited or discussed.
Broader Evidence
The PM2.5–mortality associations observed from the various
analyses of the ACS CPS-II cohort are consistent with a much
broader body of evidence from other studies. As examples,
these include studies of other cohorts from the United
States19-26 Europe,27-29 and Canada.30,31 In addition, meta-
analytic estimates of the PM2.5–mortality associations based
on a 2013 meta-analysis of the overall literature18 are also
provided for comparison purposes in Figure 1.
Previous studies of the ACS CPS-II cohort consistently
demonstrated PM2.5–mortality associations with cardiovascular
mortality.7,9 There has also been substantial work in exploring
and understanding the biological pathways and mechanisms
linking PM2.5 exposures and cardiovascular disease and
death.32-35 Similarly, the ACS CPS-II cohort has demonstrated
PM2.5–mortality associations with lung cancer mortality,
3,12,14
and recently, the International Agency for Research on Cancer
concluded, based on multiple sources of evidence, that particu-
late matter in outdoor air pollution is a cause of human lung
cancer (group 1).36 Enstrom8 presents no results for cardiovas-
cular or lung cancer mortality and largely dismisses the substan-
tial and growing literature regarding relevant pathophysiological
pathways and related biological mechanisms.
The Global Burden of Diseases, Injuries, and Risk Factors
Study 2015 (conducted by the Institute for Health Metrics and
Evaluation) identified ambient PM2.5 air pollution as the 5th
leading risk factor for global mortality, contributing to approx-
imately 4.2 million deaths in 2015.37,38 These results are based
on recent and comprehensive estimates from ACS CPS-II
cohort studies and 23 other peer-reviewed studies of long-
term exposure to PM2.5 and mortality from cause-specific car-
diovascular and respiratory disease and lung cancer. These
results underscore the importance of PM2.5 as a substantial
determinant of mortality in the general population. Conse-
quently, these results also suggest substantial health benefits
from further reductions in ambient air pollution.
In summary,wewelcome thoughtful criticismof our research.
But the study byEnstromdoes not contribute to the larger body of
evidence on the health effects of PM2.5, as it does not utilize
adequate approaches for exposure assessment, suitable methods
for linking participants to exposure, and sufficient statistical con-
trol for potential confounding factors and fails to recognize the
larger body of evidence on PM2.5 exposure and disease risk.
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